Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
3 ER Cases
Which patient has nerve agent poisoning? 9 year-old with miosis, agitation, copious secretions, uncontrolled urination. HR 120. RR 16/shallow. Sat 83%15 year-old with generalized seizure, tongue fasciculations, absent gag, absent reflexes2 year-old old with fussiness/diarrhea progressing to impaired consciousness, hypotonia
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Nerve Agents in Children
Josh Rotenberg MD MMSFellow, Pediatric Neurology
Staff Pediatrician, WRAMC & NNMCAssistant Professor of Pediatrics, USUHS
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Nerve Agents in Children
Background: Scope of the ProblemBackground: The agentsDiagnosisIsolation/DeconTreatmentPediatric Issues
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: Scope of the Problem
CWA in US– the most important act of terrorism in which
CWA was attempted to use a was the World Trade Center bombing in 1993.
the explosive used by the terrorists contained sufficient cyanide to contaminate the entire structure. Fortunately, the cyanide was destroyed by the blast
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: Scope of the Problem
Police foil terror plot to use sarin gas in London (Filed: 18/02/2001)
Bin Laden British cell planned gas attack on European Parliament (Filed: 16/09/2001)
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: Scope of the
Problem
Iran-Iraq war (1984-1988) – UN confirmed that Iraq used Tabun and other
organophosphorous nerve agents
Sarin and Sulphur mustard used on Kurds in Northern Iraq
Iraq has weaponized VX - 4 tonsGulf-War: large, urban civil popualation threatened for first time since WW1
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Sarin Attacks in Japan
Matsumoto Japan, June 19947 died, 58 admitted, 600 injured
Tokyo Subway March 1995
Sarin released at several points in the Tokyo subway
11 killed, 5,500 injured
secondary contamination of the house staff in more than 20%
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: The agents
Nerve agents include:–Tabun (GA)–Sarin (GB)–Soman (GD), and –VX
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: The agents
Originally developed as insectisides more powerful than organophosphates
Tabun is easiest and cheapest to manufacture. – Described as a starter agent for CW
program. Some consider most likey to be used as terrorist agent.
Sarin has been used in terrorist attacksVX “only exists in military stockpiles”
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: The agents
Exist as a liquid or a gasLiquid is colorless (g-type) amber-colored (VX)Gas can be odorless, fruity (tabun) or slight camphor odor (soman) Vary in volatility – some more persistent than others– Sarin as volatile as water– VX very persistent
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Background: The agents
Toxic effects depend on the concentration of the agent inhaled and the time exposed to the agent.– LD50 - 100 mg/m3 for 1 minute is
equivalent to 50 mg/m3 for 2 minutes
Note the vapor density– Sarin 4.86– VX 9.2
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
When would you launch a sarin attack?
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
How do nerve agents work?
Irreversible phosphorylation of cholinesterase enzymes at acetycholine receptors– Nicotinic– Muscarinic– CNS– Adrenal
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Nerve Agents-Mucosal Absorption
Nature and onset of signs and symptoms vary by route of absorption. – Gases may be absorbed through any part of the
respiratory tract: mucosa of the nose and mouth to the alveoli of the lungs.
Aerosol particles – > than 5 µm tend to remain in the upper respiratory tract– < than 1 µm tend to be breathed in and out again,
although some of these smaller particles may be retained.
They may also be directly absorbed by the eye/skin/GI tract
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Nerve Agents - Absorption via Skin
Agents which penetrate the skin may form temporary reservoirs so that delayed absorption may occur (less so, that OPP). Even the vapor of some agents can penetrate the intact skin and intoxication may follow. Wounds/abrasions (even minor injuries caused by shaving ) present areas which are more permeable than intact skin. The penetration of agents through the GI tract or abrasions may not neccessarily be accompanied by irritation or damage to the surfaces concerned.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Neuromuscular Effects
Twitching Weakness Paralysis Respiratory failure
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Autonomic Nervous System Effects
– Reduced Vision
– Small pupil size
– Drooling
– Sweating
– Diarrhea
– Nausea
– Abdominal pain
– Vomiting
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Eyes -- Miosis
most common findingMatsumoto - 134/219 -2.5 mm or less
improved with atropineResolved in a month
– Impaired acuity in 124/219– Blurry vision
Visual DarknessOcular pain
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Central Nervous System Effects
– Headache
– Convulsions
– Coma
– Respiratory arrest
– Confusion
– Slurred speech
– Depression
– Respiratory depression
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Delayed (Chronic) CNS Effects
Giddiness, anxiety, jitteriness, restlessness, emotional lability, excessive dreaming, insomnia, nightmares, headaches, tremor, withdrawal and depression, drowsiness difficulty concentrating, slowness on recall, confusion, slurred speech, ataxia. bursts of slow waves of elevated voltage in EEG, especially on hyperventilation,
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Cause of death In the absence of treatment– anoxia resulting from airway obstruction,
weakness of the muscles of respiration and central depression of respiration.
Airway obstruction – due to pharyngeal muscular collapse, – upper airway and bronchial secretions, – bronchial constriction and – occasionally laryngospasm and paralysis of the
respiratory muscles.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Cause of death
With adequate pulmonary support/toilet and atropine, the individual may survive several lethal doses of a nerve agent. However, if the exposure has been many times the lethal dose, death may occur despite treatment as a result of respiratory arrest and cardiac arrhythmia. When overwhelming doses of the agent are absorbed quickly, death occurs rapidly without orderly progression of symptoms.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Other symptoms
Headachecough sore throat
Can persist for weeks
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Differential Diagnosis
Sudden Mass casualties - no sign of trauma Suspect airborne toxin
Hypoxemic, miosis, profuse secretions Anti -Cholinesterase agentUnconscious, non-hypoxemic Cyanide– venous blood gasses arterialized
Less acute causes of respiratory problems Bo-tox - paralysis, absent reflexes ARDS like picture-anthrax,plague,phosgene
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Diagnosis: Treatment: institute rapidly based on clinical judgment Can measure RBC levels of acetycholinesterase– Assess treatment and recovery.
– Insensitive as a screen Matsumoto: ChE decreased in 43% of severely affectedTokyo: decreased in 74% of admiitted4% have genetic low levelsHave genetic high levels, lose 50%, still be nlOne call to lab, 3 send outs-time is critical
Clinical presentation is likely to vary in children.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Isolation/Decon
Decontamination is necessaryDogma– 0.05% bleach- people– 0.5% household bleach - equipment
Truth: Use what is available– Good results can be obtained with such
widely differing means as talcum powder, flour, soap and water, or special decontaminants.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Isolation/DeconIsolation and Decon are necessary in the field– Hot, Warm, Cold Zone - Triage in hot and cold zones
– Tokyo: Most casualties arrive in POVFirst responders may also be early casualties– Rotate health care workers in “hot zone”
23 % health care workers had some sort of physical disorder, though mild. – symptoms included ocular pain, headache, sore
throat, dyspnea, nausea, dizziness, and nose pain
– none was seriously affected
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Triage: Tokyo Subway, St. Lukes
Mild severity– miosis, rhinorrhea, and mild headache
Moderate severity – victims were immobile or complained of
moderate degree dyspnea, vomiting, severe headache or with neurologic complication like fasciculation
Critical severity – victims had cardiac or respiratory arrest.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Treatment
Atropine, respiratory support (secretion management)Antidotes must be given quickly– But may still be effective if given late,
even in extremis
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Treatment
Atropine-give liberally to dry secretions– average total dose in adult 50 mg
Pralidoxime 1 g over 5-10 minFasciculations, Seizures treated with benzodiazepinesIM not optimal but acceptable
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Mark 1 - USA/USAF
Atropine - 2 mg (0.7 ml)2 PAM Cl autoinjector dispenses 600 mg/2 ml
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Prophylaxis
PyridostigmineMilitary use only
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Supportive therapy for CWA exposure include
Pulmonary treatment/toilet– supplementary oxygen – bronchodilators
Fluids, elctrolytes, nutritionHypothermiaEye care Attention to skin lesions, Treatment of complicating infections
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Pediatric considerations/guidanceAntidotes - DosagesOrgan System SpecificTokyo Subway, 1995– 16 children– 5 pregnant women
Matsumoto, 1994– age 3-89
– mean 33 y.o.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Treatments: Pediatric Dosage
Atropine - ACLS protocol – 0.02 to 0.05 mg/kg to a maximum of 2 mg.
May repeat q 10 minutes to reverse cholinergic symptoms.
Min dose – 0.1 mgMax dose - 0.5 mg child; 1 mg adolescent
Should we be liberalwith atropine?
ACLS dosing may not be sufficient
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Atropine Poisoning in Israeli Children
– n=268, 92% of pediatric ER’s– Most cases accidental; 7.5% intentional
by parents expecting exposure– doses of 0.01 to 0.17 mg/kg– no fatalities,seizures– 0.045 to 0.17 mg/kg - mild effects
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Treatments: Pediatric Dosage
Pralidoxime (US) 2-PAM, Protopam– 20-50 mg/kg x 1 im/iv/sc. May repeat in 1
hour to relieve muscle weakness (nicotinic)
– Watch for muscle rigidity, laryngospasm, tachycardia
– n.b. others used in Europe and Israel– Some studies suggest continuous infusion
may be betterno data in kids
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Treatments: Pediatric Dosage
Diazepam – For severe seizures/status epilepticus30d to 5 y – 0.05 to 0.3 mg/kg IV to a max of 5mg/dose. May repeat q15-30 minutes5 y.o. – 0.05 to 0.3 mg/kg IV to a max of 10 mg/dose.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
CNSCarbamate and Organophosphate poisoning in young children -- Pediatric Emerg Care, April 1999
– age 2-8, Median 2.8
Stupor/Coma 100%Hypotonia 100%Miosis 56%Diarrhea,, Bradycardia, Salivation 25-37%Pulmonary edema 37%
Predominance of CNS findings in children?– Immaturity of blood brain vs. developmental effect
on CNS cholinesterase
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Pulmonary
Increased minute volume and vapor density increases dose of vapor to childrenSmaller airway will be more easily obstructed– bronchoconstriction and secretions
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Dermatologic
Skin absorption of liquid may be significant consideration in infants. Large surface to volume ratio in children compared to adultsFat soluble agents (less than OPP)Breaks in skin may permit easier penetration of agent. – Incidence of atopy is approx 4%.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Dermatologic
Decontamination - Bleach is a mild to moderate mucosal irritant. 0.5% bleach may cause contact dermatittisIn children can present like “prickly heat”, erythema, edema, blistering.
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Environmental Exposure/ Temperature Regulation:
Hypothermia - Patients will be fully disrobed before decontamination– cold water/bleach solution.
Adequate cover, clothing, diapers should be available for parents and children.Watch for delayed effects with warming
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Feeding
No information is available regarding breast feeding. – However, nerve agents are less lipid
soluble than OPP.
Breast feeding mothers should be encouraged to pump and discard.– Until when? No research done
Institutions should be ready to support infant feedings
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Developmental-Triage and care
Mild and early symptoms may be missed due to a child’s inability to communicate symptoms of pain and pressure. Alternatively, a physician might dismiss signs symptoms such as sleepiness, hypotonia, cramps, rhinnorhea as typical of other childhood illnesses and behavior.What will we do with the mother/infant pairs in decon?Unescorted children?
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Long-Term Effects:
CNS: Organophospate poisoning literature suggests chronic CNS (neurocognitive/cerebellar) and PNS impairmentCarcinogenicity: Limited data in animals suggests no effect. One study suggests genotoxicity in human lymphocytesReproductive Effects: Limited data in animals suggests no effect. – Tokyo - well babies
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
Take Home Goodies
Mass cas + no trauma=Inhalant
Presentation varies with: agent, state, absorption, temperature
Autonomic, CNS, muscular symptoms
Start treatment based on suspicion– atropine, respiratory support– Consider diazepam, pralidoxime
Pediatric Issues: acute and chronic
Joshua Rotenberg MD MMS, Pediatric Joshua Rotenberg MD MMS, Pediatric NeurologyNeurology
AAP Guidelines